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Best known as energy storing molecules and core-components of cellular membranes, lipids are
also important regulators of cell signaling. They can compartmentalize signaling by organizing
membrane-topology into specialized sub-domains in the plasma membrane or into intracellular
microvesicles (1, 2). Covalent lipid-modification of proteins can direct their localization to partic-
ular membrane compartments. Non-covalent membrane lipid interactions control the mechanics
of T cell receptor (TCR) signal transduction (3, 4). Membrane lipids can also act as second-
messengers, as exemplified by the phosphoinositide-3-kinase (PI3K) lipid-product phosphatidyli-
nositol(3,4,5)trisphosphate (PIP3) in lymphocytes, the topic of several reviews here, and of a
recent dedicated Research Topic in Frontiers in Immunology (5). Other lipids can also act as
intracellular or extracellular messengers, or govern cell function at the level of metabolism. Not
surprisingly, lipid producing and metabolizing enzymes and lipid downstream-effectors have
gained considerable attention as potential therapeutic targets for immune disorders, blood can-
cer, and even aging (5, 6) (and this Research Topic), and certain lipids are being used as
therapeutics (7).
The 11 reviews in this Research Topic highlight some of the most important, or most recently
discovered lipid functions in T cells. So and Croft review evidence that besides the TCR and
costimulatory CD28, members of the Tumor-Necrosis-Factor (TNFR) superfamily contribute to
sustained PI3K-pathway activation in T cells and beyond (8). Based on their studies of the TNFR
OX40, the authors suggest a model where ligand-induced TNFR oligomerization concentrates PI3K
and Akt close to TCR/CD28 signalosomes. This may contribute to the well-established TNFR-
requirements for T cell clonal expansion, survival, and memory. The authors also review evidence
for TNFR-mediated PI3K control in other cells and discuss important open questions, such as
which precise molecular interactions link TNFRs to PI3K/Akt. Wang and colleagues review the
components and mechanisms of PI3K-signaling in lymphocytes (9). They discuss how PI3Ks are
activated to produce PIP3, the mechanisms limiting PIP3 production, and the role of PIP3 removal
by lipid-phosphatases. Next, the authors discuss how PIP3 specifically binds to effector proteins
such as Akt and Tec-kinases via their PH domains to control lymphocyte biology. They also discuss
a less well-appreciated mechanism of how soluble inositol-phosphates can control PI3K-signaling
by acting as PIP3-analogs. An increasing number of studies suggest that this non-canonical way of
controlling PI3K-function has broad importance in hematopoiesis (9–11). The authors conclude
by reviewing how protein-ligands of PIP3-binding domains provide yet another level of control as
exemplified by their recent work on calmodulin–PH domain interactions. A complementing review
by Srivastava and colleagues focuses on PIP3 metabolizing lipid-phosphatases in T cells (12). The
paramount tumor suppressor function of PTEN, critical functions in effector and regulatory T cells,
and recent efforts to target them pharmacologically underscore the importance of PIP3 removal by
lipid-phosphatases. Among them, PTEN reverses the PI3K-reaction, whereas SHIP1/2 also control
signaling by producing PI(3,4)P2, which recruits and controls effector proteins additional to Akt and
Tec-family kinases.
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But PIP3 and its immediate derivatives are not the only impor-
tant phosphoinositides in immune cells. Nunès and Guittard dis-
cuss recent evidence for functions of PI5P in TCR signaling (13).
They introduce the enzymes governing PI5P metabolism, review
PI5P-binding domains in effector proteins such as Dok, and dis-
cuss potential PI5P functions in T cells.While inositol-phosphates
are produced through hydrolysis of the phosphodiester-bond
between the glycerol and inositol-phosphate moieties of phos-
phatidylinositols, phosphatidylinositol-deacylation by phospho-
lipase A generates glycerophosphoinositols. Containing both
glycerol- and phosphoinositol-moieties, glycerophosphoinositols
are soluble and may have intracellular signaling roles. They
can also be excreted to potentially exert paracrine functions.
Patrussi et al. discuss metabolism and potential immunomodu-
latory roles for these little-studied messengers (14). In particu-
lar, glycerophosphoinositol(4)phosphate can augment TCR and
CXCR4 chemokine receptor signaling inT cells.Unknown cellular
receptors for, and physiological relevance of glycerophosphoinos-
itols indicate exciting research opportunities in this young field.
Other phosphoinositide derivatives with important func-
tions in T cells are the PI3K-substrate phosphatidylinosi-
tol(4,5)bisphosphate (PIP2), diacylglycerol (DAG) and phospha-
tidic acid (PA). Jun and colleagues review how these lipids orches-
trate intricate interactions of Ras guanine-nucleotide-exchange-
factors, Ca2+, adaptor- and effector proteins to control both kinet-
ics and topology of Ras-activation in T cells (15). The authors
discuss the roles of allosteric and feedback mechanisms, Ras-
acylation, and complex interactions between the Ras- and PI3K-
pathways. A complementing review by Krishna and Zhong dis-
cusses how diacylglycerol-kinases (DGK) phosphorylate DAG
into PA to control T cell development and function, in partic-
ular to maintain self-tolerance (16). The authors review roles
for known DAG-effectors and little-understood PA-effectors in T
cells, potential contributions of DAGor PAmetabolism, andDGK
functions in other immune cells. Improved antiviral and antitu-
mor activities of DGK-deficient T cells might indicate potential
translational relevance, but as the authors point out, more studies
are needed.
Moving beyond phosphoinositides, Nicolaou and colleagues
(7) and Lone and colleagues (17) review the diverse func-
tions of polyunsaturated fatty acid (PUFA)-derivatives in T
cells. PUFA-lipids can modulate membrane-associated signalo-
somes by altering membrane composition, or act as precursors
of secreted signaling-lipids. Both reviews first discuss biosyn-
thesis and metabolism of eicosanoids, including prostanoids,
leukotrienes, fatty acid epoxides, and endocannabinoids, and then
review their diverse and often complex functions in T cell biology
and disease. They further discuss the therapeutic potential of
PUFA, a particularly interesting topic given the exploration of
dietary PUFA as antiinflammatory agents, and the interest in
targeting the prostanoid PGE2 to improve immunotherapies for
cancer or infections (7, 18).
Another lipid-derived messenger with important immune-
regulatory functions is the cholesterol-derivative vitamin D3.
Kongsbak and colleagues review how its binding to the
transcription-factor vitamin-D-receptor (VDR) controls T cell
development, differentiation, and function (19). They describe
the mechanisms controlling VDR expression and activity, and
discuss roles for VDR downregulation in promoting autoimmune
diseases or in dampening innate immunity during certain infec-
tions. Autoimmune disease-reversal by VDR-agonist/antibiotic
combinations suggests translational relevance and possible
contributions to the long-known but ill-understood links
betweenmicrobial infections and the etiology of autoimmmunity.
Available as nutrients, vitamin D3, the lipid-related vitamin A,
and short-chain fatty acids (20) all are potential lead-agents for
therapeutic immunomodulation.
Finally, Procaccini and colleagues discusses how adipokine-
hormones – produced by fat tissue and best known to influence
energy-homeostasis and neuroendocrine function – may link
metabolism with immunity (21). This area has recently gained
increasing attention because of reported links between obesity,
chronic inflammation, and various diseases, including cancer. The
authors introduce the cellular and molecular components linking
fat tissue and immune system and then review the often contro-
versial, potential immunoregulatory roles of leptins, adiponectins,
and other adipokines.
Altogether, the reviews in this Research Topic highlight how
recent progress has profoundly altered and expanded our under-
standing of lipid functions in T cell biology but also raised many
interesting questions. Rather than merely acting as membrane
components and energy stores, lipids have emerged as important
and multifaceted signaling molecules both inside and outside of
T cells. We believe that this Frontiers in Immunology Research
Topic provides its readers with a broad and stimulating basis to
follow these important developments. In this sense, we thank all
the authors for their outstanding contributions.
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